PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Disease Rheumatic Fever 6,356 20 0.00 -1.00 0.00 0.47
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
Cancer 1,053,491 Disease Target CRG-2 41 1 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Disease Carcinoma Endometrial 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Disease Skin Rash 3,684 578 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Disease Bipolar Affective Disorder 1,690 6 0.00 -1.00 0.00 0.48
Cancer 1,053,491 Disease Target Elastase 13,875 382 0.00 -0.99 0.03 0.53
Cancer 1,053,491 Disease Disease Hypothyroidism 23,397 982 0.01 -0.98 0.04 0.55
Cancer 1,053,491 Disease Target BMP-2 3,889 128 0.00 -0.98 0.03 0.53
Cancer 1,053,491 Disease Disease Nephrotic Syndrome 14,681 172 0.00 -0.99 0.01 0.50
Cancer 1,053,491 Disease Disease Seizures 66,465 489 0.00 -1.00 0.01 0.49
Cancer 1,053,491 Disease Disease Orthopedic Disorders 168 5 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Drug Arranon (Nelarabine)- FDA 12 2 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.53
Cancer 1,053,491 Disease Target CA 50 1,293 178 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target Beta-R1 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Drug Doxazolidine 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Disease Carcinoma Renal 6 4 0.00 -0.58 0.67 0.57
Cancer 1,053,491 Disease Target ERBB3 1,154 481 0.01 -0.76 0.42 0.60
Cancer 1,053,491 Disease Disease Scabies 2,670 16 0.00 -1.00 0.01 0.49
Cancer 1,053,491 Disease Disease Muscle Relaxation 4,706 79 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Disease Bacterial Infections 14,248 531 0.00 -0.98 0.04 0.54
Cancer 1,053,491 Disease Disease Proteinuria 28,803 538 0.00 -0.99 0.02 0.52
Cancer 1,053,491 Disease Target Complement Component C1q 167 4 0.00 -0.99 0.02 0.52
Cancer 1,053,491 Disease Target BDNF 11,163 130 0.00 -0.99 0.01 0.50
Cancer 1,053,491 Disease Target D(2) Dopamine Receptor 1,559 5 0.00 -1.00 0.00 0.47
Cancer 1,053,491 Disease Disease Ankylosing Spondylitis 9,665 80 0.00 -1.00 0.01 0.49
Cancer 1,053,491 Disease Drug Doxorubicin Hydrochloride 581 204 0.01 -0.81 0.35 0.59
Cancer 1,053,491 Disease Drug Doxorubicin Analogue 25 8 0.00 -0.82 0.32 0.56
Cancer 1,053,491 Disease Target DJ-1/PARK7 21 4 0.00 -0.90 0.19 0.55
Cancer 1,053,491 Disease Disease Dysfunctional Uterine Bleeding 778 61 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
Cancer 1,053,491 Disease Disease Lung Cancer 91,416 91,416 0.29 -0.00 1.00 0.74
Cancer 1,053,491 Disease Target CD34 24,598 2,119 0.01 -0.95 0.09 0.57
Cancer 1,053,491 Disease Target DEP-1 88 7 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target Cardiotrophin-1 351 12 0.00 -0.98 0.03 0.52
Cancer 1,053,491 Disease Drug Dromostanolone Propionate 3 2 0.00 -0.58 0.67 0.57
Cancer 1,053,491 Disease Target Galectin-1 1,131 229 0.01 -0.89 0.20 0.57
Cancer 1,053,491 Disease Target CCL8 197 16 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Disease Septic Arthritis 4,121 28 0.00 -1.00 0.01 0.49
Cancer 1,053,491 Disease Disease Inflammation 252,734 15,973 0.03 -0.96 0.06 0.59
Cancer 1,053,491 Disease Target Activin A 2,048 124 0.00 -0.97 0.06 0.54
Cancer 1,053,491 Disease Target Equilibrative Nucleoside Transporter 1 211 71 0.00 -0.81 0.34 0.58
Cancer 1,053,491 Disease Drug Doxifluridine 267 206 0.01 -0.48 0.77 0.60
Cancer 1,053,491 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target CKBB 57 4 0.00 -0.96 0.07 0.54